Results 211 to 220 of about 6,484,256 (294)

NUCLEAR BATTERY--THERMOCOUPLE TYPE. Quarterly Report No. 1 for January 1, 1957-March 31, 1957

, 1957
B ertram C. Blanke
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Alteration of Metabolic Profile in Patients with Narcolepsy Type 1. [PDF]

Metabolites
Hakim MA, Purba W, Sanni A, Bhuiyan MMAA, Talih F, Lanza G, Kobeissy F, Plazzi G, Pizza F, Ferri R, Mechref Y.   +10 more
europepmc   +1 more source

Agglutination of Alkalescens-Dispar type 1 by dyes and heavy metal ions

, 1956
Kazue Ueno, Shoichiro SUZUKI, Uzuhiko Kurimoto   +2 more
openalex   +2 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Satisfaction with life in young adults with type 1 diabetes mellitus. [PDF]

Sci Rep
Stefanowicz-Bielska A, Rąpała M, Mazuryk K, Kawa M, Dygaszewicz E.   +4 more
europepmc   +1 more source

Statistical Research of Ilmenite Type Arc Welding Electrods (Report 1)

, 1956
S. Ando, S. Mori
openalex   +2 more sources

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Type 1 Diabetes Genetics Consortium.

J Clin Endocrinol Metab
Onengut-Gumuscu S, Concannon P, Akolkar B, Erlich HA, Julier C, Morahan G, Nierras CR, Pociot F, Todd JA, Rich SS.   +9 more
europepmc   +1 more source

Transition and transfer experiences and their correlates in emerging adults with type 1 diabetes. [PDF]

BMJ Open Diabetes Res Care
Vallmark M, Brorsson AL, Acuña Mora M, Bratt EL, Moons P, Saarijärvi M, Chisalita S, Sparud-Lundin C.   +7 more
europepmc   +1 more source